首页> 外文期刊>World Journal of Gastroenterology >Construction of prokaryotic expression system of 2 148-bp fragment from cagA gene and detection of cagA gene, CagA protein in Helicobacter pylori isolates and its antibody in sera of patients
【24h】

Construction of prokaryotic expression system of 2 148-bp fragment from cagA gene and detection of cagA gene, CagA protein in Helicobacter pylori isolates and its antibody in sera of patients

机译:cagA基因2 148 bp片段原核表达系统的构建及幽门螺杆菌分离株中cagA基因,CagA蛋白及其抗体的检测

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To construct a prokaryotic expression system of a Helicobacter pylori (H pylori) cagA gene fragment and establish enzyme-linked immunosorbent assays (ELISA) for detecting CagA and its antibody, so as to understand the manner in which the infection of CagA-expressing H pylori (CagA~+ H pylori) isolates cause diseases. METHODS: H pylori strains in gastric biopsy specimens from 156 patients with positive results in rapid urease test were isolated. PCR was used to detect the frequency of cagA gene in the 109 H pylori isolates and to amplify a 2 148-bp fragment (cagA1) of cagA gene from a clinical strain Y06. A prokaryotic expression system of cagA1 gene was constructed, and the expression of the target recombinant protein (rCagA1) was examined by SDS-PAGE. Western blotting and immunodiffusion assay were employed to determine the immunoreactivity and antigenicity of rCagA1, respectively. Two ELISAs were established to detect CagA expression in 109 H pylori isolates and the presence of CagA antibody in the corresponding patients' sera, and the correlations between infection with CagA~+ H pylori and gastritis as well as peptic ulcer were analyzed. RESULTS: Of all the clinical specimens obtained, 80.8% (126/156) were found to have H pylori isolates and 97.2% of the isolates (106/109) were positive for cagA gene. In comparison with the reported data, the cloned cagA1 fragment possessed 94.83% and 93.30% homologies with the nucleotide and putative amino acid sequences, respectively. The output of rCagA1 produced by the constructed recombinant prokaryotic expression system was approximately 30% of the total bacterial protein. rCagA1 was able to bind to the commercial antibody against the whole-cells of H pylori and to induce the immunized rabbits to produce antibody with an immunodiffusion titer of 1∶4. A proportion as high as 92.6% of the H pylori isolates (101/109) expressed CagA and 88.1% of the patients' serum samples (96/109) were CagA antibody-positive. The percentage of CagA~+ H pylori strains (97.9%) isolated from the biopsy specimens of peptic ulcer appeared to be higher than that from gastritis (88.5%), but the difference was not statistically significant (Χ~2=3.48, P>0.05). CONCLUSION: rCagA1 produced by the prokaryotic expression system constructed in this study possesses good immunoreactivity and antigenicity, and the established ELISAs can be used to detect CagA of H pylori and its antibody. H pylori isolates show high frequencies of cagA gene and CagA expression, but the infections by CagA~+ H pylori strains are not the most decisive factors to cause gastric diseases.
机译:目的:构建幽门螺杆菌cagA基因片段的原核表达系统,建立酶联免疫吸附法(ELISA)检测CagA及其抗体,以了解表达CagA的感染方式。幽门螺杆菌(CagA〜+幽门螺杆菌)分离物可引起疾病。方法:分离156例胃活检标本中的幽门螺杆菌菌株,快速尿素酶检测结果阳性。 PCR用于检测109 H幽门分离株中cagA基因的频率,并从临床菌株Y06扩增cagA基因的2 148 bp片段(cagA1)。构建了cagA1基因的原核表达系统,并通过SDS-PAGE检测了靶重组蛋白(rCagA1)的表达。 Western blotting和免疫扩散测定分别用于确定rCagA1的免疫反应性和抗原性。建立了两种ELISA方法,分别检测109株幽门螺杆菌中CagA的表达以及相应患者血清中CagA抗体的存在,并分析了CagA〜+ H幽门菌与胃炎以及消化性溃疡之间的相关性。结果:在获得的所有临床标本中,发现有80.8%(126/156)具有幽门螺杆菌分离株,并且97.2%(106/109)分离株的cagA基因呈阳性。与报道的数据相比,克隆的cagA1片段与核苷酸和推定的氨基酸序列分别具有94.83%和93.30%的同源性。由构建的重组原核表达系统产生的rCagA1的产量约为总细菌蛋白的30%。 rCagA1能够与针对幽门螺杆菌全细胞的商业抗体结合,并诱导免疫兔产生1∶4的免疫扩散滴度的抗体。高达92.6%的幽门螺杆菌分离物(101/109)表达CagA,而患者血清样本(96/109)的88.1%为CagA抗体阳性。从消化性溃疡活检标本中分离出的CagA〜+ H幽门螺杆菌菌株的百分比(97.9%)似乎高于胃炎(88.5%),但差异无统计学意义(Χ〜2 = 3.48,P> 0.05)。结论:构建的原核表达系统产生的rCagA1具有良好的免疫反应性和抗原性,所建立的ELISA方法可用于检测幽门螺杆菌CagA及其抗体。幽门螺杆菌分离株显示出高频率的cagA基因和CagA表达,但CagA〜+幽门螺杆菌菌株的感染并不是引起胃病的最主要决定性因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号